Active Research Protocols
- 11-C-0191 – Phase 1 and Pharmacokinetic Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma
- 12-C-0136 – A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014